A double-blind randomised controlled trial protocol comparing dexamphetamine and placebo effectiveness for obesity management in primary care settings

Obesity is a growing health and economic burden. This study investigates dexamphetamine, an inexpensive drug, as a potential safe and effective treatment for obesity when combined with diet and lifestyle changes over six months in general practice. The trial is a double-blind, randomised, placebo-controlled study with a six-month active treatment phase and two years of follow-up. Participants are randomised 1:1 to receive either dexamphetamine or placebo, starting at 5 mg twice daily, with…

via https://pubmed.ncbi.nlm.nih.gov/42111443/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20260516011005&v=2.20.0


Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>